These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Insights into structure and activity of natural compound inhibitors of pneumolysin. Li H; Zhao X; Deng X; Wang J; Song M; Niu X; Peng L Sci Rep; 2017 Feb; 7():42015. PubMed ID: 28165051 [TBL] [Abstract][Full Text] [Related]
84. Characterization of pneumolysin from Streptococcus pneumoniae, interacting with carbohydrate moiety and cholesterol as a component of cell membrane. Lim JE; Park SA; Bong SM; Chi YM; Lee KS Biochem Biophys Res Commun; 2013 Jan; 430(2):659-63. PubMed ID: 23211600 [TBL] [Abstract][Full Text] [Related]
85. Dual Role of Hydrogen Peroxide as an Oxidant in Pneumococcal Pneumonia. Mraheil MA; Toque HA; La Pietra L; Hamacher J; Phanthok T; Verin A; Gonzales J; Su Y; Fulton D; Eaton DC; Chakraborty T; Lucas R Antioxid Redox Signal; 2021 Apr; 34(12):962-978. PubMed ID: 32283950 [No Abstract] [Full Text] [Related]
86. A conserved tryptophan in pneumolysin is a determinant of the characteristics of channels formed by pneumolysin in cells and planar lipid bilayers. Korchev YE; Bashford CL; Pederzolli C; Pasternak CA; Morgan PJ; Andrew PW; Mitchell TJ Biochem J; 1998 Feb; 329 ( Pt 3)(Pt 3):571-7. PubMed ID: 9445384 [TBL] [Abstract][Full Text] [Related]
87. Protective role of Cav-1 in pneumolysin-induced endothelial barrier dysfunction. Batori RK; Chen F; Bordan Z; Haigh S; Su Y; Verin AD; Barman SA; Stepp DW; Chakraborty T; Lucas R; Fulton DJR Front Immunol; 2022; 13():945656. PubMed ID: 35967431 [TBL] [Abstract][Full Text] [Related]
88. Influence of subinhibitory concentrations of protein-synthesis-inhibiting antibiotics on production and release of the pneumococcal virulence factor pneumolysin in vitro. Spreer A; von Ruden C; Mitchell TJ; Eiffert H; Nau R Chemotherapy; 2007; 53(5):327-31. PubMed ID: 17728540 [TBL] [Abstract][Full Text] [Related]